[go: up one dir, main page]

CN113702148A - Freezing embedding agent and application thereof in frozen section - Google Patents

Freezing embedding agent and application thereof in frozen section Download PDF

Info

Publication number
CN113702148A
CN113702148A CN202110997603.3A CN202110997603A CN113702148A CN 113702148 A CN113702148 A CN 113702148A CN 202110997603 A CN202110997603 A CN 202110997603A CN 113702148 A CN113702148 A CN 113702148A
Authority
CN
China
Prior art keywords
frozen
tissue
parts
embedding
freezing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110997603.3A
Other languages
Chinese (zh)
Inventor
陈莉莉
尹盈
唐清明
陈广进
彭金枫
孙纪威
罗贝贝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Original Assignee
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Hospital Tongji Medical College Huazhong University of Science and Technology filed Critical Union Hospital Tongji Medical College Huazhong University of Science and Technology
Priority to CN202110997603.3A priority Critical patent/CN113702148A/en
Publication of CN113702148A publication Critical patent/CN113702148A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36Embedding or analogous mounting of samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/42Low-temperature sample treatment, e.g. cryofixation

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明涉及组织切片技术领域,尤其涉及一种冰冻包埋剂及其在冰冻切片中的应用。所述冰冻包埋剂以重量份计,包括蔗糖10~30份、聚乙烯吡络烷酮1~5份和明胶3~10份。本发明在冰冻包埋剂中使用明胶、蔗糖和聚乙烯吡络烷酮,充分发挥三种物质的特性,在应用于冰冻切片时,可以显著减少切片时的皱卷现象,同时可以在速冻后拥有和骨组织相似的硬度,并且在速冻过程中细胞结构不受损害。本发明提供的冰冻包埋剂包埋的骨组织,经过冰冻切片后,组织完整,在后续组织染色时呈现更完整的结构。

Figure 202110997603

The invention relates to the technical field of tissue sections, in particular to a frozen embedding agent and its application in frozen sections. The freezing embedding agent, in parts by weight, includes 10-30 parts of sucrose, 1-5 parts of polyvinylpyrrolidone and 3-10 parts of gelatin. In the invention, gelatin, sucrose and polyvinylpyrrolidone are used in the freezing embedding medium, and the characteristics of the three substances are fully exerted. It has a hardness similar to that of bone tissue, and the cell structure is not damaged during the quick freezing process. The bone tissue embedded in the freezing embedding agent provided by the present invention has intact tissue after being frozen sectioned, and exhibits a more complete structure during subsequent tissue staining.

Figure 202110997603

Description

Freezing embedding agent and application thereof in frozen section
Technical Field
The invention relates to the technical field of tissue slices, in particular to a frozen embedding medium and application thereof in frozen slices.
Background
Tissue section technique is a commonly used method for observing morphological structure of cell tissue, and is commonly used in pathology or forensic science to study, observe and judge morphological changes of cell tissue. At present, for bone tissues, the slicing method is mainly divided into three methods, one method is to carry out slicing after the bone tissues subjected to decalcification are embedded by paraffin; one is to carry out frozen section after the bone tissue after decalcification is embedded by using a frozen embedding medium; yet another approach is to perform hard tissue sectioning of bone tissue without decalcification.
The principle of the method lies in that paraffin is fully immersed into tissues through the steps of dehydration, transparence, paraffin embedding and the like, so that tissue blocks are hardened, the tissue blocks are favorably sliced, the original structure of the tissues can be perfectly preserved, and the method can be used for observing tissue images under a microscope.
The frozen section is a method for rapidly cooling tissues to a certain hardness under a low temperature condition and then slicing, the manufacturing process is quicker and simpler compared with a paraffin section, and the frozen section can be applied to rapid pathological diagnosis in an operation.
Hard tissue sections are a method of generating very thin complete sections from hard tissues or large specimens and then observing the sections, but the cost is high, the microstructure is not as fine as that of paraffin sections, the thickness of the sections is generally 10 μm, and the sections cannot present some staining forms such as bone marrow microvessels.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a freezing embedding medium and application thereof in frozen sections.
According to a first aspect, the invention provides a freezing embedding medium, which comprises 10-30 parts by weight of sucrose, 1-5 parts by weight of polyvinylpyrrolidone and 3-10 parts by weight of gelatin.
The coating further comprises 15-25 parts by weight of cane sugar, 2-5 parts by weight of polyvinylpyrrolidone and 5-10 parts by weight of gelatin.
Further, the method comprises the following steps of:
15-20% of cane sugar, 2-3% of polyvinylpyrrolidone, 5-8% of gelatin and the balance of water.
Wherein, the gelatin forms gel at room temperature, and forms a three-dimensional network structure when cooled to below 0 ℃, thereby effectively reducing the wrinkle phenomenon during the frozen section. However, the difference between the hardness of the formed gel and that of the bone tissue is large in a cooling state, and slicing is not facilitated. The invention further solves the problem through polyvinylpyrrolidone, and the polyvinylpyrrolidone has good dispersibility and film forming property and has thickening effect, so that the hardness of the embedding agent after quick freezing is close to the hardness of the decalcified bone tissue. In addition, the invention also adds sucrose which can inhibit the dynamic performance of water molecules, thereby inhibiting the growth of ice crystals and playing a good role of a freezing protective agent in the quick-freezing process.
In a second aspect, the invention provides a method of frozen sectioning, using said frozen embedding medium for embedding.
Further, the embedding comprises:
heating and thawing the frozen embedding medium; completely placing the sliced tissues in the freezing embedding medium and cooling to be gelatinous to obtain sliced tissue gel; and placing the section tissue gel in liquid nitrogen for 10-15 seconds.
Further, after the sliced tissue gel is placed on the surface of liquid nitrogen for 45-60 seconds, the sliced tissue gel is placed at the temperature of-20 ℃ to-25 ℃ for slicing.
The bone tissue after decalcification is placed in a freezing embedding medium (for example, the freezing section embedding medium is added into a freezing section embedding box) to be immersed in the bone tissue, and after the bone tissue forms gel at room temperature, the gel is attached to the surface of liquid nitrogen to be quickly frozen for 45-60 seconds until the embedding block is completely whitened, so that the bone tissue freezing time is effectively shortened, and the formation of ice crystals is reduced. The temperature range of 0 ℃ to-5 ℃ is the maximum ice crystal generation zone, the quick freezing time is too long, and when the embedded tissue is taken out from liquid nitrogen, the embedding agent is cracked due to the rapid temperature rise.
Further, heating to 55-65 ℃; and/or, the cooling is to 20-30 ℃.
Further, before the embedding, pretreatment is also included;
the pretreatment comprises the following steps: carrying out gradient dehydration treatment on the slice tissues for 6-12 hours by using a dehydrating agent 1, and carrying out gradient dehydration treatment on the slice tissues for 6-12 hours by using a dehydrating agent 2;
the dehydrating agent 1 comprises 15-20 parts by weight of cane sugar, and the dehydrating agent 2 comprises 25-30 parts by weight of cane sugar, 1-3 parts by weight of polyvinylpyrrolidone and 5-10 parts by weight of DMSO.
Wherein, the sucrose can reduce the water content in the bone tissue so as to reduce the formation of ice crystals in the quick-freezing process, the DMSO can further reduce the formation of ice crystals in cells in the quick-freezing process of the bone tissue, and the polyvinylpyrrolidone can penetrate into the bone tissue so as to improve the overall structural strength of the marrow cavity and reduce the possibility of the fragmentation of tissues in the marrow cavity in the process of frozen sectioning.
Further, the sliced tissue is decalcified bone tissue.
The invention further provides the application of the freezing embedding medium in the embedding of the frozen section of the bone tissue.
The invention has the following beneficial effects:
the invention uses gelatin, sucrose and polyvinylpyrrolidone in the frozen embedding medium, gives full play to the characteristics of the three substances, can obviously reduce the wrinkle phenomenon in slicing when being applied to frozen slices, simultaneously can have the hardness similar to that of bone tissues after being frozen, and does not damage the cell structure in the process of quick freezing.
The bone tissue embedded by the freezing embedding medium provided by the invention is not easy to wrinkle and break in the process of preparing a freezing section, the tissue is relatively complete and not easy to crack, the section with the thickness of 8-100 mu m can be cut, and the subsequent tissue staining presents a more complete structure, such as a bone tissue microvascular structure and a vascular reticular structure.
In addition, the tissue section prepared by the frozen section method provided by the invention has stronger adhesive capacity to a glass slide in the preparation process, also shows excellent anti-slide-off capacity on a pathological-grade frosted glass slide, and effectively reduces the occurrence of the anti-slide-off phenomenon in the subsequent tissue immunostaining.
The frozen section method provided by the invention has the advantages of low cost, non-toxic and harmless components of the frozen embedding medium, good biological safety, good immunogenicity retention of various proteins of bone tissues, contribution to subsequent immune tissue staining and capability of omitting the step of antigen repair.
Drawings
FIG. 1 is a schematic diagram of immunofluorescence observation results under a confocal microscope of a mouse femur frozen section provided in example 1 of the present invention; the microscope magnification was 100 ×.
FIG. 2 is a schematic diagram of immunofluorescence observation results under a confocal microscope of a mouse femur frozen section provided in example 1 of the present invention; the microscope magnification was 600 ×.
FIG. 3 is a schematic diagram of natural light observation results of a mouse femur frozen section under a confocal microscope according to example 1 of the present invention; the microscope magnification was 40 ×.
FIG. 4 is a schematic diagram of immunofluorescence observation results under a confocal microscope of a mouse femur frozen section provided in example 2 of the present invention; microscope magnification was 200 x.
FIG. 5 is a schematic diagram of the observation result of the frozen mouse femur section under confocal microscope according to example 2 of the present invention; the microscope magnification was 40 ×.
Detailed Description
The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
The reagents and instruments used in the following examples are commercially available unless otherwise specified.
Example 1
The embodiment provides a method for frozen sectioning, which specifically comprises the following steps:
1. taking bone tissues: the mice are sacrificed, bone tissues at the position of the thighbone are taken, attached soft tissues are stripped, and the mice are placed in 4% paraformaldehyde for fixation for 24 hours;
2. decalcification treatment: washing bone tissue with PBS for 3 times, transferring the bone tissue into 10% EDTA decalcification solution with volume 20 times, placing in a rotary shaking table, and replacing the decalcification solution every day for one week;
3. embedding pretreatment: embedding pretreatment: placing the tissue sample into a dehydrating agent 1 for soaking for 8 hours, and then placing the tissue sample into a dehydrating agent 2 for soaking for 8 hours, so that the damage of ice crystals generated in the quick-freezing process of the tissue sample to the tissue is reduced;
the dehydrating agent 1 comprises the following components in percentage by mass: 20 percent of cane sugar and the balance of deionized water, wherein the dehydrating agent 2 comprises the following components: 30% of sucrose, 5% of DMSO, 2% of polyvinylpyrrolidone and the balance of deionized water.
4. Quick-freezing embedding: placing the pretreated tissue sample into a frozen section embedding medium, sticking an embedding block on the surface of liquid nitrogen, quickly freezing for 45 seconds, and transferring to-20 ℃ for storage;
the frozen section embedding medium comprises the following components in percentage by mass: 15% of sucrose, 2% of polyvinylpyrrolidone, 5% of gelatin and the balance of deionized water.
5. Freezing and slicing: and (4) carrying out frozen sectioning on the embedded sample, and setting the temperature to be-20 ℃ to obtain a frozen tissue section.
6. Tissue staining: the obtained mouse femur frozen tissue sections are subjected to immunofluorescence staining with the staining indexes of CD31, EMCN and DAPI nuclear staining, and finally, the sections are sealed by using an anti-fluorescence quencher.
7. And (3) observation by a confocal microscope: the stained bone tissue sections were observed by confocal microscopy.
The slicing results are shown in fig. 1 and fig. 2, and the lumen-like structure of the blood vessel can be clearly seen in fig. 1 (low power microscope) and fig. 2 (high power microscope), which illustrates that the bone tissue embedded by the freezing embedding agent provided by the invention can present a relatively complete structure after the freezing slicing and the subsequent staining of the slices, thereby facilitating the subsequent pathological study.
In addition, the section obtained in the slicing process is shown in fig. 3, and as can be seen from fig. 3, the section obtained by the invention is complete in tissue and is not easy to break. In addition, in the present embodiment, in the slicing process, 20 slices are obtained, wherein 90% of the slices are complete, and under the same condition, the slice integrity rate (based on the fact that the slice can be used for staining and subsequent observation) of the commercially available OCT embedding agent (purchased from SAKURA) is 30-40%, which indicates that the slice integrity rate obtained by freezing the slices is significantly improved by the freezing embedding agent provided by the present invention.
Example 2
1. Taking bone tissues: the mice are sacrificed, bone tissues at the thighbone are taken, attached soft tissues are stripped, and the mice are placed in 4% paraformaldehyde for fixation for 24 hours;
2. decalcification treatment: washing bone tissue with PBS for 3 times, transferring the bone tissue into 10% EDTA decalcification solution with volume 20 times, placing in a rotary shaking table, and replacing the decalcification solution every day for one week;
3. embedding pretreatment: placing the tissue sample into a dehydrating agent 1 for soaking for 8 hours, and then placing the tissue sample into a dehydrating agent 2 for soaking for 8 hours, so that the damage of ice crystals generated in the quick-freezing process of the tissue sample to the tissue is reduced;
the dehydrating agent 1 comprises the following components in percentage by mass: 20 percent of cane sugar and the balance of deionized water, wherein the dehydrating agent 2 comprises the following components: 30% of sucrose, 5% of DMSO, 2% of polyvinylpyrrolidone and the balance of deionized water.
4. Quick-freezing embedding: placing the pretreated tissue sample into a frozen section embedding medium, sticking an embedding block on the surface of liquid nitrogen, quickly freezing for 45 seconds, and transferring to-20 ℃ for storage;
the frozen section embedding medium comprises the following components in percentage by mass: 20% of sucrose, 2% of polyvinylpyrrolidone, 8% of gelatin and the balance of deionized water.
5. Freezing and slicing: and (4) carrying out frozen sectioning on the embedded sample, and setting the temperature to be-20 ℃ to obtain a frozen tissue section.
6. Tissue staining: the obtained mouse femur frozen tissue sections are subjected to immunofluorescence staining with the staining indexes of CD31, EMCN and DAPI nuclear staining, and finally, the sections are sealed by using an anti-fluorescence quencher.
7. And (4) microscopic observation: the stained bone tissue sections were observed by a microscope.
The staining result of the section is shown in fig. 4, and the vascular structure can be clearly seen from fig. 4, which shows that the bone tissue embedded by the freezing embedding medium provided by the invention can present a more complete structure after the freezing section and the subsequent section staining, thereby facilitating the subsequent pathological research.
In addition, the section obtained in the slicing process is shown in fig. 5, and as can be seen from fig. 5, the section obtained by the invention is complete in tissue and is not easy to break. In the slicing process, 20 slices are obtained in total, wherein 85% of the slices are complete.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.

Claims (10)

1.一种冰冻包埋剂,其特征在于,以重量份计,包括蔗糖10~30份、聚乙烯吡络烷酮1~5份和明胶3~10份。1. A frozen embedding agent, characterized in that, in parts by weight, comprising 10-30 parts of sucrose, 1-5 parts of polyvinylpyrrolidone and 3-10 parts of gelatin. 2.根据权利要求1所述的冰冻包埋剂,其特征在于,以重量份计,包括蔗糖15~25份、聚乙烯吡络烷酮2~5份和明胶5~10份。2 . The frozen embedding agent according to claim 1 , wherein, in parts by weight, it comprises 15-25 parts of sucrose, 2-5 parts of polyvinylpyrrolidone and 5-10 parts of gelatin. 3 . 3.根据权利要求1或2所述的冰冻包埋剂,其特征在于,以质量百分比计,包括:3. freezing embedding agent according to claim 1 and 2 is characterized in that, in mass percent, comprising: 蔗糖15~20%、聚乙烯吡络烷酮2~3%和明胶5~8%,余量为水。15-20% of sucrose, 2-3% of polyvinylpyrrolidone and 5-8% of gelatin, and the balance is water. 4.一种冰冻切片方法,其特征在于,采用权利要求1-3任一项所述冰冻包埋剂进行包埋。4. A method for frozen section, characterized in that, embedding is carried out using the frozen embedding agent described in any one of claims 1-3. 5.根据权利要求4所述的冰冻切片方法,其特征在于,所述包埋包括:5. The frozen section method according to claim 4, wherein the embedding comprises: 加热融解所述冰冻包埋剂;将切片组织完全置于所述冰冻包埋剂中并冷却至凝胶状得到切片组织凝胶;将所述切片组织凝胶置于液氮中10~15秒。Heat and thaw the frozen embedding medium; place the sliced tissue completely in the frozen embedding medium and cool it to a gel-like state to obtain a sliced tissue gel; place the sliced tissue gel in liquid nitrogen for 10 to 15 seconds . 6.根据权利要求4或5所述的方法,其特征在于,在将所述切片组织凝胶置于液氮表面45~60秒之后,将所述切片组织凝胶置于-20℃~-25℃的条件下切片。6. The method according to claim 4 or 5, wherein after placing the sliced tissue gel on the surface of liquid nitrogen for 45-60 seconds, the sliced tissue gel is placed at -20°C~- Sectioned at 25°C. 7.根据权利要求4-6任一项所述的冰冻切片方法,其特征在于,所述加热为加热至55~65℃;和/或,所述冷却为冷却至20~30℃。7. The frozen section method according to any one of claims 4-6, wherein the heating is heating to 55-65°C; and/or the cooling is cooling to 20-30°C. 8.根据权利要求4-7任一项所述的冰冻切片方法,其特征在于,在所述包埋前,还包括预处理;8. The frozen section method according to any one of claims 4-7, characterized in that, before the embedding, further comprising pretreatment; 所述预处理包括:将切片组织置于冰冻保护剂中6~12小时;The pretreatment includes: placing the sliced tissue in a cryoprotectant for 6-12 hours; 所述冰冻保护剂以重量份计包括DMSO 10~20份、聚乙烯吡络烷酮1~3份。The cryoprotectant includes, in parts by weight, 10-20 parts of DMSO and 1-3 parts of polyvinylpyrrolidone. 9.根据权利要求4-8任一项所述的冰冻切片方法,其特征在于,所述切片组织为脱钙骨组织。9. The frozen section method according to any one of claims 4-8, wherein the sectioned tissue is demineralized bone tissue. 10.权利要求1-3任一项所述冰冻包埋剂在骨组织冰冻切片的包埋中的应用。10. The application of the cryo-embedding agent according to any one of claims 1-3 in the embedding of frozen sections of bone tissue.
CN202110997603.3A 2021-08-27 2021-08-27 Freezing embedding agent and application thereof in frozen section Pending CN113702148A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110997603.3A CN113702148A (en) 2021-08-27 2021-08-27 Freezing embedding agent and application thereof in frozen section

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110997603.3A CN113702148A (en) 2021-08-27 2021-08-27 Freezing embedding agent and application thereof in frozen section

Publications (1)

Publication Number Publication Date
CN113702148A true CN113702148A (en) 2021-11-26

Family

ID=78656199

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110997603.3A Pending CN113702148A (en) 2021-08-27 2021-08-27 Freezing embedding agent and application thereof in frozen section

Country Status (1)

Country Link
CN (1) CN113702148A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114097766A (en) * 2021-12-03 2022-03-01 山东数字人科技股份有限公司 Specimen embedding liquid and preparation method thereof
CN120028107A (en) * 2025-04-18 2025-05-23 长春赛默瑞特科技有限公司 A colored frozen embedding agent, a preparation method thereof, and a frozen embedding agent kit

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017017283A1 (en) * 2015-07-30 2017-02-02 Qiagen Gmbh Method of preparing a frozen biological sample
CN108572105A (en) * 2018-04-13 2018-09-25 山东中医药大学 A kind of preparation method of frozen section of brain tissue
CN108956253A (en) * 2018-09-10 2018-12-07 生工生物工程(上海)股份有限公司 Frozen section embedding medium and its preparation method and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017017283A1 (en) * 2015-07-30 2017-02-02 Qiagen Gmbh Method of preparing a frozen biological sample
CN108572105A (en) * 2018-04-13 2018-09-25 山东中医药大学 A kind of preparation method of frozen section of brain tissue
CN108956253A (en) * 2018-09-10 2018-12-07 生工生物工程(上海)股份有限公司 Frozen section embedding medium and its preparation method and application

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANJALI P KUSUMBE ET AL.: "Sample preparation for high-resolution 3D confocal imaging of mouse skeletal tissue", 《NATURE PROTOCOLS》 *
潘瑞炽 等: "《植物细胞工程》", 31 August 2008 *
罗玉敏 等: "《脑血管病实验方法学》", 30 April 2014 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114097766A (en) * 2021-12-03 2022-03-01 山东数字人科技股份有限公司 Specimen embedding liquid and preparation method thereof
CN120028107A (en) * 2025-04-18 2025-05-23 长春赛默瑞特科技有限公司 A colored frozen embedding agent, a preparation method thereof, and a frozen embedding agent kit

Similar Documents

Publication Publication Date Title
Dempsey et al. A copper block method for freezing non‐cryoprotected tissue to produce ice‐crystal‐free regions for electron microscopy: I. Evaluation using freeze‐substitution
CN113702148A (en) Freezing embedding agent and application thereof in frozen section
EP2968419A1 (en) Molded placental tissue compositions and methods of making and using the same
CN107185051A (en) Polyvinyl alcohol hydrogel and preparation method thereof
CN103512784B (en) The method for making of plant tissue slice, plant tissue slice and application thereof
Lott et al. Protein bodies from the cotyledons of Cucurbita maxima
Nei Mechanism of freezing injury to erythrocytes: effect of initial cell concentration on the post-thaw hemolysis
CN113575572A (en) Ultra-fast rewarming method for blood vessel vitrification preservation
Oegema Jr et al. A simple cryopreservation method for the maintenance of cell viability and mechanical integrity of a cultured cartilage analog
Wang et al. Cryopreservation of cell/hydrogel constructs based on a new cell-assembling technique
CN107843609B (en) Method for preparing carp muscle extracellular connective tissue scanning electron microscope sample
CN114563432B (en) Frozen sample processing method for scanning electron microscope three-dimensional structure reconstruction experiment
CN112293407A (en) A method for programmed cryopreservation of ovarian tissue
CN111937862A (en) Testis tissue cryopreservation method based on single seminiferous tubule perfusion
Yamaguchi et al. Rapid freezing using sandwich freezing device for good ultrastructural preservation of biological specimens in electron microscopy
CN106719599B (en) Method for reducing ice crystal damage of deep low temperature frozen tissue and organ
Eberechukwu et al. Xylene-Free Histoprocessing Using an Alternative Method: Effect of Microwave Temperature
Ramalingam et al. Rapid Coverslip Removal and Immunohistochemical Analysis: A Comparative Study.
Xu et al. Effects of freezing rates and cryoprotectant on thermal expansion of articular cartilage during freezing process
WO2021045122A1 (en) Method for producing frozen body of three-dimensional tissue aggregate of retinal pigment epithelial cells
Zhao et al. Measurement of membrane hydraulic conductivity of bovine carotid artery endothelial cells using a perfusion microscope
Germinario et al. Preparation of tissue for scanning electron microscopy: freeze-fracturing as a technique for enhancing visibility of structural relationships
Yamaguchi et al. Electron microscopy of biological specimens by the plasma–polymerization rapid–freeze replica method
CN1172175C (en) Attachment method of ultra-thin slices on mica surface based on atomic force microscope observation
RU2797125C1 (en) Method for preparing bone tissue samples with implanted metal for histological study

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20211126

RJ01 Rejection of invention patent application after publication